An evaluation of the impact of legislative changes on stakeholders in the South African pharmaceutical industry.
Changes in the health sector in South Africa have been widespread since 1994 with restructuring ofthe public sector being the focal point of legislation. The limelight has recently shifted focus to the health sector with the Medicine and Related Substances (MRSCA) Amendment Act, 59 of 2002 in which...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
2011
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10413/2418 |